NANOVIRICIDES INC
For the period ended Jun 30, 2024. Filed Sep 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Sep 27, 2024
NNVC$1.42+6.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets at June 30, 2024 and 2023
Balance Sheet
| | | | | | | |
|---|---|---|---|---|---|---|
| | June 30, 2024 | June 30, 2023 | ||||
| | | | | | | |
| ASSETS · · | ||||||
| CURRENT ASSETS: · · | ||||||
| Cash and cash equivalents | | $4,797,778 | | $8,149,808 | ||
| Prepaid expenses | | 172,742 | | 295,486 | ||
| Total current assets | | 4,970,520 | | 8,445,294 | ||
| | | | | | | |
| Property and equipment, net | | 7,512,463 | | 8,106,647 | ||
| | | | | | | |
| Intangible assets, net | | 325,308 | | 333,578 | ||
| | | | | | | |
| OTHER ASSETS | | | ||||
| Service agreements | | 14,562 | | 14,361 | ||
| | | | | | | |
| Total assets | | $12,822,853 | | $16,899,880 | ||
| | | | | | | |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | | | ||||
| CURRENT LIABILITIES: | | | ||||
| Accounts payable | | $376,270 | | $157,056 | ||
| Accounts payable – related party | | 720,039 | | 233,434 | ||
| Accrued expenses | | 262,467 | | 143,760 | ||
| Total current liabilities | | 1,358,776 | | 534,250 | ||
| | | | | | | |
| Other non-current liability – related party | | — | | 1,500,000 | ||
| Total liabilities | | | 1,358,776 | | | 2,034,250 |
| | | | | | | |
| COMMITMENTS AND CONTINGENCIES (NOTE 11) | | | ||||
| | | | | | | |
| STOCKHOLDERS’ EQUITY: | | | ||||
| Series A convertible preferred stock, $0.00001 par value, 10,000,000 shares designated, 892,625 and 547,674 shares issued and outstanding, at June 30, 2024 and 2023, respectively. (Note 9) | | 9 | | 5 | ||
| Common stock, $0.00001 par value; 150,000,000 shares authorized, 13,144,055 and 11,698,497 shares issued and outstanding at June 30, 2024 and 2023, respectively. (Note 8) | | 131 | | 117 | ||
| Additional paid-in capital | | 150,838,832 | | 145,946,257 | ||
| Accumulated deficit | | (139,374,895) | | (131,080,749) | ||
| Total stockholders’ equity | | 11,464,077 | | 14,865,630 | ||
| Total liabilities and stockholders’ equity | | $12,822,853 | | $16,899,880 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.